|
Volumn 136, Issue , 2015, Pages 105-110
|
Effect of inclusion complexation of meloxicam with β-cyclodextrin- and β-cyclodextrin-based nanosponges on solubility, in vitro release and stability studies
|
Author keywords
Inclusion complex; Meloxicam; Nanosponges; cyclodextrin
|
Indexed keywords
DRUG PRODUCTS;
ENCAPSULATION;
PARTICLE SIZE;
SCANNING ELECTRON MICROSCOPY;
SOLUBILITY;
STABILITY;
ZETA POTENTIAL;
ANTI-INFLAMMATORIES;
CONTROLLED RELEASE;
CRYSTALLINE NATURE;
ENCAPSULATION EFFICIENCY;
INCLUSION COMPLEX;
INCLUSION COMPLEXATION;
MELOXICAM;
NANOSPONGES;
CYCLODEXTRINS;
ANALGESIC AGENT;
ANTIINFLAMMATORY AGENT;
BETA CYCLODEXTRIN;
BETA CYCLODEXTRIN BASED NANOSPONGE;
MELOXICAM;
UNCLASSIFIED DRUG;
BETA CYCLODEXTRIN DERIVATIVE;
NANOMATERIAL;
NONSTEROID ANTIINFLAMMATORY AGENT;
THIAZINE DERIVATIVE;
THIAZOLE DERIVATIVE;
ANALGESIC ACTIVITY;
ANALYTIC METHOD;
ANIMAL EXPERIMENT;
ANIMAL MODEL;
ANTIINFLAMMATORY ACTIVITY;
ARTICLE;
COMPLEX FORMATION;
CONTROLLED DRUG RELEASE;
CONTROLLED STUDY;
CRYSTAL STRUCTURE;
DIFFERENTIAL SCANNING CALORIMETRY;
DRUG ENCAPSULATION EFFICIENCY;
DRUG FORMULATION;
DRUG SOLUBILITY;
DRUG STABILITY;
FEMALE;
IN VITRO STUDY;
IN VIVO STUDY;
INCLUSION COMPLEXATION;
INFRARED SPECTROSCOPY;
KNEADING METHOD;
MALE;
NONHUMAN;
PARTICLE SIZE;
PAW EDEMA;
PHARMACOLOGICAL PARAMETERS;
PHYSICAL MIXING;
PRIORITY JOURNAL;
RAT;
SCANNING ELECTRON MICROSCOPY;
ULTRASOUND;
X RAY POWDER DIFFRACTION;
ZETA POTENTIAL;
ANIMAL;
CHEMISTRY;
POWDER DIFFRACTION;
SOLUBILITY;
WISTAR RAT;
ANIMALS;
ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL;
BETA-CYCLODEXTRINS;
CALORIMETRY, DIFFERENTIAL SCANNING;
FEMALE;
IN VITRO TECHNIQUES;
MALE;
MICROSCOPY, ELECTRON, SCANNING;
NANOSTRUCTURES;
PARTICLE SIZE;
POWDER DIFFRACTION;
RATS;
RATS, WISTAR;
SOLUBILITY;
SPECTROSCOPY, FOURIER TRANSFORM INFRARED;
THIAZINES;
THIAZOLES;
|
EID: 84941270220
PISSN: 09277765
EISSN: 18734367
Source Type: Journal
DOI: 10.1016/j.colsurfb.2015.09.002 Document Type: Article |
Times cited : (97)
|
References (18)
|